Literature DB >> 27865468

Molecular and Cellular Changes in Breast Cancer and New Roles of lncRNAs in Breast Cancer Initiation and Progression.

M Kumar1, R S DeVaux1, J I Herschkowitz2.   

Abstract

Breast cancer is not just one disease but many variations on a theme, comprising a variety of molecular subtypes with distinct etiologies, cellular origins, treatment strategies, and prognoses. Like mRNAs and microRNAs (miRNAs), long noncoding RNAs (lncRNAs) differ dramatically in expression across breast cancer subtypes and can be used for classification. While there has been considerable emphasis on miRNAs, our knowledge is still in its infancy about the role of lncRNAs that comprise the majority of the mammalian transcriptome. In this chapter, we will review the critical functions that lncRNAs play in breast cancer development and metastatic progression. We will conclude with a discussion of current and future approaches for RNA-targeted therapeutic intervention.
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Epigenetics; Metastasis; Noncoding RNA; Targeted therapy

Mesh:

Substances:

Year:  2016        PMID: 27865468     DOI: 10.1016/bs.pmbts.2016.09.011

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  9 in total

Review 1.  LncRNAs in ocular neovascularizations.

Authors:  Yacouba Cissé; Lang Bai; Min-Ting Chen
Journal:  Int J Ophthalmol       Date:  2019-12-18       Impact factor: 1.779

Review 2.  Nuclear organization mediates cancer-compromised genetic and epigenetic control.

Authors:  Sayyed K Zaidi; Andrew J Fritz; Kirsten M Tracy; Jonathan A Gordon; Coralee E Tye; Joseph Boyd; Andre J Van Wijnen; Jeffrey A Nickerson; Antony N Imbalzano; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  Adv Biol Regul       Date:  2018-05-09

3.  Long noncoding RNA BHLHE40-AS1 promotes early breast cancer progression through modulating IL-6/STAT3 signaling.

Authors:  Rebecca S DeVaux; Ali S Ropri; Sandra L Grimm; Peter A Hall; Emilio O Herrera; Sridar V Chittur; William P Smith; Cristian Coarfa; Fariba Behbod; Jason I Herschkowitz
Journal:  J Cell Biochem       Date:  2020-01-07       Impact factor: 4.429

4.  lncRNA HEIH, an indicator of high malignancy and poor prognosis, functions as an oncogene in breast cancer.

Authors:  Cheng Chen; Cheng Gu; Qian Ren; Fanghui Ding; Qing Pan; Yicong Niu; Dachang Ma; Li Wu
Journal:  Mol Med Rep       Date:  2020-07-23       Impact factor: 2.952

5.  Long non-coding RNA small nucleolar RNA host gene 7 is upregulated and promotes cell proliferation in thyroid cancer.

Authors:  Li Chen; Jing Zhu; Ling-Jie Zhang
Journal:  Oncol Lett       Date:  2019-08-27       Impact factor: 2.967

6.  The long non-coding RNA GHSROS facilitates breast cancer cell migration and orthotopic xenograft tumour growth.

Authors:  Patrick B Thomas; Inge Seim; Penny L Jeffery; Manuel D Gahete; Michelle Maugham; Gabrielle J Crisp; Andrew Stacey; Esha T Shah; Carina Walpole; Eliza J Whiteside; Colleen C Nelson; Adrian C Herington; Raúl M Luque; Rakesh N Veedu; Lisa K Chopin
Journal:  Int J Oncol       Date:  2019-10-04       Impact factor: 5.650

Review 7.  Long Noncoding RNA 00472: A Novel Biomarker in Human Diseases.

Authors:  Dan-Yang Ren; Xin-Rong Yuan; Cai-Xia Tu; Jian-Ling Shen; Yun-Wei Li; Ai-Hua Yan; Yi Ru; Hui-Yun Han; Yan-Ming Yang; Yan Liu; Hui-Ying Li
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

8.  Effects of long non-coding RNA myocardial infarction-associated transcript on retinal neovascularization in a newborn mouse model of oxygen-induced retinopathy.

Authors:  Yu Di; Yue Wang; Xue Wang; Qing-Zhu Nie
Journal:  Neural Regen Res       Date:  2021-09       Impact factor: 5.135

Review 9.  Beyond DNA: the Role of Epigenetics in the Premalignant Progression of Breast Cancer.

Authors:  Rebecca S DeVaux; Jason I Herschkowitz
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-10-10       Impact factor: 2.673

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.